FIBROGEN INC — Director's Dealing 2016

Feb 25, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: FIBROGEN INC (FGEN)
CIK: 0000921299
Period of Report: 2016-02-22

Reporting Person: Yu K Peony (VP, Clinical Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-02-22	Common Stock	A	35294	$0.00	Acquired	222389	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-02-22	Stock Option (Right to Buy)	$19.39	A	60000	Acquired	2026-02-22	Common Stock (60000)	Direct

Footnotes

F1: Represents the grant of restricted stock units that vest over time.

F2: Twenty-five percent of the shares subject to the option vest on March 1, 2017, and the remainder vests in equal amounts quarterly thereafter for the following three years.